CPH — Cipher Pharmaceuticals Share News
0.000.00%
Last trade - 00:00- CA$339.41m
- CA$327.17m
- $50.45m
Canada's Cipher Pharma Q2 revenue falls on lower Natroba sales amid reduced Medicaid coverage
Canada Research Roundup: Altius Minerals, Cipher Pharmaceuticals, Suncor Energy
Canada's Cipher Pharmaceuticals Q1 net income jumps 135% on lower costs
Brief: Cipher Pharmaceuticals Q1 Net Income USD 6.163 Million
Canada's Cipher Pharmaceuticals Q4 net income rises
Brief: Cipher Pharmaceuticals Q4 Net Income USD 13.311 Million
Cipher Pharma Q3 revenue up 24% on higher Natroba sales
Brief: Cipher Pharmaceuticals Receives Successful Arbitration Award
Brief: Cipher Pharmaceuticals Q2 Adjusted EBITDA USD 7.586 Million Vs. IBES Estimate USD 6.41 Million
Brief: Cipher Pharmaceuticals Partner Moberg Pharma AB Reports Topline Data In Mob-015 Phase 3 Study
Brief: Cipher Pharmaceuticals Enhances Leadership Team With Appointment Of New Chief Business Officer
Canada Research Roundup: Canadian National Railway, Denison Mines, Primaris REIT
Brief: Cipher Pharma Acquires Profitable Growth Dermatology Products From ParaPRO For $89.5 Mln
Brief: Cipher Pharmaceuticals Announces Intention To Commence Substantial Issuer Bid, Aggregate Price Up To $6 Mln Canadian Dollars
Brief: Cipher Partner, Moberg Pharma Announces Approval For MOB-015 In The European Union
Brief: Cipher Pharmaceuticals Reports First Quarter Results, Highlighted By Record Cash Per Share And Strong Financial Flexibility
Brief: Cipher Pharmaceuticals Reports Q4 Results
Brief: Cipher Pharmaceuticals Strengthens Leadership Team With Appointment Of New CFO
Brief: Cipher Pharmaceuticals Reports First Quarter 2022 Results